Margetuximab
About
Therapy type: Hormone therapy
Therapy strategy: HER2 inhibition
Mappings
NCI Thesaurus: Margetuximab (ncit:C91733)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (1) | HER2-positive | Invasive Breast Carcinoma | Capecitabine, Margetuximab | |
| FDA (1) | HER2-positive | Invasive Breast Carcinoma | Eribulin, Margetuximab | |
| FDA (1) | HER2-positive | Invasive Breast Carcinoma | Gemcitabine, Margetuximab | |
| FDA (1) | HER2-positive | Invasive Breast Carcinoma | Margetuximab, Vinorelbine |